Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

51.61 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Dec 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 246,432
Open 51.61
Bid (Size) 52.22 (200)
Ask (Size) 52.35 (400)
Prev. Close 51.61
Today's Range 51.61 - 51.61
52wk Range 43.08 - 93.80
Shares Outstanding N/A
Dividend Yield 4.26%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Novo Nordisk A/S-Spons ADR (NYSE:NVO): A Prime Candidate for Steady Dividend Income ↗
Novo Nordisk (NVO) exemplifies a strong dividend stock with a 3.83% yield, a history of increases, and robust profitability for sustainable passive income. 
Via Chartmill
News headline image
Stock Market Today, Dec. 23: U.S. Stocks Hold Near Records on Narrow Tech-Led Gains ↗
Mega-cap tech and AI stocks carried major indexes in thin holiday trading, while healthcare strength after Novo Nordisk’s Wegovy pill approval added selective support amid a resilient economic... 
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks

Performance

YTD
-41.0%
-41.0%
1 Month
+14.8%
+14.8%
3 Month
-13.3%
-13.3%
6 Month
-27.0%
-27.0%
1 Year
-41.8%
-41.8%

More News

Read More
News headline image
Why Novo Nordisk Stock Popped Today ↗
Via The Motley Fool
News headline image
Novo Nordisk Stock Soars as "Wegovy Pill" Gains FDA Approval, Reshaping Obesity Market
Via MarketMinute
Novo Nordisk, Trinity Biotech, Starfighters Space, VisionWave, ServiceNow: Stocks Making The Biggest Moves Today ↗
Via Stocktwits
Novo Nordisk’s Worst Year In Over Four Decades May Be Ending — Thanks To A Weight-Loss Pill ↗
Via Stocktwits
News headline image
Stock Market Today, Dec. 23: Novo Nordisk Surges After FDA Approves Oral Wegovy Weight Loss Pill ↗
Via The Motley Fool
Topics Stocks
News headline image
Novo Nordisk Breaks the Mold: Oral Obesity Breakthrough Sends Shares to New Heights as Pharma Landscape Shifts
Via MarketMinute
Topics Economy
News headline image
Which stocks are most active on Tuesday? ↗
Via Chartmill
News headline image
Thin Trading and High Hopes: Markets Eye a 'Santa Claus Rally' as 2025 Draws to a Close
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Santa Claus Rally Solidifies as S&P 500 Secures Third Consecutive Winning Session Amid Economic Resilience
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
These stocks are gapping in today's session ↗
Via Chartmill
News headline image
The Great Biotech Rebound: How Pricing Clarity Rescued the Drug Sector in 2025
Via MarketMinute
Topics Economy
Nasdaq, S&P 500 Futures Tread Caution Ahead Of GDP, Confidence Data: Why NVO, ZIM, SIDU Are On Traders' Radar Today ↗
Via Stocktwits
Topics Stocks
News headline image
Novo Nordisk Stock Soars After Hours As FDA Greenlights Wegovy Pill For Weight Loss ↗
Via Stocktwits
News headline image
The Incretin Empire: Eli Lilly’s (LLY) Path to a $1 Trillion Market Cap and Beyond
Via PredictStreet
Topics Economy Intellectual Property
News headline image
The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth
Via PredictStreet
Topics Economy Intellectual Property
News headline image
Should You Forget Novo Nordisk and Buy This Magnificent High-Yield Drug Stock Instead? ↗
Via The Motley Fool
News headline image
Novo Nordisk (NYSE:NVO) Identified as a 'Decent Value' Stock with Strong Fundamentals ↗
Via Chartmill
News headline image
2026 Market Outlook: Key Themes and Predictions
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Prediction: 1 Healthcare Giant Set to Soar in 2026 ↗
Via The Motley Fool
Topics ETFs
News headline image
The Weight of a Trillion: Inside Eli Lilly’s Pharmaceutical Hegemony
Via PredictStreet
Topics Economy World Trade
News headline image
Better Buy in 2026: Novo Nordisk or Intuitive Surgical? ↗
Via The Motley Fool
News headline image
Better Pharmaceutical Buy: Eli Lilly vs. Novo Nordisk ↗
Via The Motley Fool
News headline image
Pfizer's Muted 2026 Outlook Sends Ripples Through Pharmaceutical Sector
Via MarketMinute
Topics Intellectual Property

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 51.61
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 12/23/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.